Literature DB >> 16796681

Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo.

Despina Smirlis1, Sylvia N Bisti, Evangelia Xingi, Georgia Konidou, Maria Thiakaki, Ketty P Soteriadou.   

Abstract

Episomal expression of Leishmania histone H1 sense mRNAs in Leishmania major promastigotes was found previously to result in overexpression of this molecule and to reduce parasite infectivity in vitro. Herein, we evaluated the in vivo infectivity of these transfectants, in BALB/c mice, and showed that it is dramatically reduced. No lesions were observed in this group of mice and this was associated with an extremely low number of parasites both in the footpad and in the draining lymph nodes. Interestingly, the transfectants-reduced infectivity was associated with a delay in their cell-cycle progression and differentiation to axenic amastigotes, assessed in vitro. Therefore, the dramatic reduction in their infectivity may be attributed to the above-mentioned phenotypic modifications. As the metazoan linker histone H1(0) homologue is known to delay cell-cycle progression in mammalian cells we investigated whether its Leishmania counterpart, which possesses homology to its C-terminal region, when expressed in mammalian cells may also affect their cell-cycle progression. It was thus shown that Leishmania histone H1 expressed in COS7 and NIH 3T3 cells, delays cell-cycle progression in these cells too. The latter strengthens the phenotype observed in Leishmania and provides evidence that critical functions of histone H1 molecules are conserved throughout evolution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796681     DOI: 10.1111/j.1365-2958.2006.05205.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  11 in total

Review 1.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

2.  Effect of human urine on cell cycle and infectivity of Leismania species promastigotes in vitro.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Serhat Elcicek; Rabia Cakir Koc; Olga N Oztel
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

3.  Histone H1 of Trypanosoma cruzi is concentrated in the nucleolus region and disperses upon phosphorylation during progression to mitosis.

Authors:  Luciana M Gutiyama; Julia P Chagas da Cunha; Sergio Schenkman
Journal:  Eukaryot Cell       Date:  2008-02-15

4.  Molecular and cellular characterization of an AT-hook protein from Leishmania.

Authors:  Ben L Kelly; Gyanendra Singh; Ashok Aiyar
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

5.  The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.

Authors:  Amalia Papadaki; Anastasia S Politou; Despina Smirlis; Maria P Kotini; Konstadina Kourou; Thomais Papamarcaki; Haralabia Boleti
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

6.  Quantitative proteomic analysis of amastigotes from Leishmania (L.) amazonensis LV79 and PH8 strains reveals molecular traits associated with the virulence phenotype.

Authors:  Eloiza de Rezende; Rebeca Kawahara; Mauricio S Peña; Giuseppe Palmisano; Beatriz S Stolf
Journal:  PLoS Negl Trop Dis       Date:  2017-11-27

7.  Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence.

Authors:  Daniel Alfonso Urrea; Jorge Duitama; Hideo Imamura; Juan F Álzate; Juanita Gil; Natalia Muñoz; Janny Alexander Villa; Jean-Claude Dujardin; José R Ramirez-Pineda; Omar Triana-Chavez
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

8.  Total Phenolic Fraction (TPF) from Extra Virgin Olive Oil: Induction of apoptotic-like cell death in Leishmania spp. promastigotes and in vivo potential of therapeutic immunomodulation.

Authors:  Kalliopi Karampetsou; Olga S Koutsoni; Georgia Gogou; Apostolis Angelis; Leandros-Alexios Skaltsounis; Eleni Dotsika
Journal:  PLoS Negl Trop Dis       Date:  2021-01-11

9.  Histone H1 plays a role in heterochromatin formation and VSG expression site silencing in Trypanosoma brucei.

Authors:  Megan L Povelones; Eva Gluenz; Marcin Dembek; Keith Gull; Gloria Rudenko
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

10.  Trypanosoma brucei histone H1 inhibits RNA polymerase I transcription and is important for parasite fitness in vivo.

Authors:  Ana C Pena; Mafalda R Pimentel; Helena Manso; Rita Vaz-Drago; Daniel Pinto-Neves; Francisco Aresta-Branco; Filipa Rijo-Ferreira; Fabien Guegan; Luis Pedro Coelho; Maria Carmo-Fonseca; Nuno L Barbosa-Morais; Luisa M Figueiredo
Journal:  Mol Microbiol       Date:  2014-07-14       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.